Home LiteratureArticle Details
PMID: 7539869 Published · ppublish English Journal Article

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.

The Journal of urology ·Vol. 154 ·No. 1 ·1995-07-00 ·Pages 69-71

Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR

Abstract

Neovascularization of tumor tissue (tumor angiogenesis) is considered essential for tumor growth, proliferation and eventually metastasis. Microvessel density or count, a measure of tumor angiogenesis, correlates with clinical outcome in skin, breast, lung and prostate carcinomas. To determine whether an association of tumor angiogenesis and nodal metastasis exists in invasive bladder cancer, microvessel counts in 41 primary invasive stages (T2 to 4,NX,M0) bladder cancers were assessed. Microvessels were identified by immunostaining of endothelial cells for factor VIII-related antigen. Microvessels were scored in selected areas showing active neovascularization, either counting a 200 x field (0.74 mm.2) or by using a 10 x 10 square ocular grid (0.16 mm.2). The microvessel count correlated with the presence of occult lymph node metastases (p < 0.0001) by both techniques. The mean microvessel count in 27 patients without lymph node metastases was 56.2 microvessels per 200 x field (standard deviation [SD] 29.5, range 7 to 130) or 28.6 microvessels per grid (SD 14.4, range 4 to 65). The 14 patients with histologically proved lymph node metastases showed mean 138.1 microvessels per 200 x fields (SD 37.9, range 82 to 202) or 74.7 microvessels per grid (SD 14.4, range 43 to 115). Good correlation was noted between area and grid counting (r = 0.97). Tumor T stage, grade and the presence of vascular or lymphatic invasion did not correlate with the presence of lymph node metastases (p = 0.41, 0.59 and 0.26, respectively). Microvessel count may provide important information regarding the risk of occult metastasis in patients with invasive bladder carcinomas.

MeSH Terms
Capillaries/pathology Carcinoma, Squamous Cell/blood supply,pathology,secondary Carcinoma, Transitional Cell/blood supply,pathology,secondary Endothelium/blood supply Female Humans Lymphatic Metastasis/pathology Male Middle Aged Neoplasm Invasiveness Neoplasm Staging Neoplasms, Unknown Primary/blood supply,pathology Neovascularization, Pathologic/pathology Pelvis Risk Factors Staining and Labeling Urinary Bladder Neoplasms/blood supply,pathology Venules/pathology von Willebrand Factor
Chemicals
von Willebrand Factor
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Jaeger T M
Department of Urology, University of California, San Francisco School of Medicine 94143-0738, USA.
Weidner N
Chew K
Moore D H
Kerschmann R L
Waldman F M
Carroll P R
Article Info
Journal
The Journal of urology
Abbr.
J Urol
ISSN
0022-5347
Published
1995-07-00
Pages
69-71
Language
English
Region
United States
NLM ID
0376374
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com